Premarket Approval (PMA)

Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.

• Device: Eluvia Drug-Eluting Vascular Stent System
• Generic Name: Stent, superficial femoral artery, drug-eluting
• Applicant: Boston Scientific Corp.; One Scimed Place; Maple Grove, MN 55311
• PMA Number: P180011
• Date Received: 04/13/2018
• Decision Date: 09/18/2018
• Product Code: NIU
• Docket Number: 18M-3548
• Notice Date: 09/20/2018
• Advisory Committee: Cardiovascular
• Clinical Trials: NCT02574481
• Expedited Review Granted?: No
• Combination Product: Yes

Approval Order Statement  
Approval for the ELUVIA Drug-Eluting Vascular Stent System. The device is indicated for improving luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters (RVD) ranging from 4.0 - 6.0 mm and total lesion lengths up to 190 mm.

• Approval Order: Approval Order
• Summary: Summary of Safety and Effectiveness
• Labeling: Labeling; Labeling Part 2
• Post-Approval Study: Show Report Schedule and Study Progress
• Supplements: S001 S002 S003 S004 S005 S007 S008 S009 S010 S011 S012 ; S013 S014 S015 S016 S017 S018 S019 S020 S021 S022 S023 S024 ; S025 S026 S027 S028 S029 S030 S031 S032 S033 S034 S035 S036 ; S037 S038 S039 S040 S041 S042 S043 S044 S045 S046 S047 S048 ; S049 S050 S051 S052 S053 S054 S055 S056 S058